BRTXBioRestorative Therapies, Inc.同业对比
BioRestorative Therapies, Inc. 与SIC 8090 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BRTX本股 | $38M#10 | — | 12.5x#9 | 105.5x#12 | -10.3%#7 | -58.6%#9 | -4350.1%#12 | -470.7%#10 | -23478.3%#7 | — | -95.2%#2 | — |
| DVA | $11.4B#1 | 13.4x#3 | — | 0.8x#4 | 6.5%#3 | -13.8%#7 | 15.0%#2 | — | 34.3%#1 | — | — | — |
| SHC | $5.2B#3 | 31.7x#6 | 7.8x#8 | 4.4x#9 | 5.7%#4 | 75.6%#3 | 25.6%#1 | 11.7%#4 | 6.4%#4 | 8#1 | — | — |
| PGNY | $2.2B#4 | 31.7x#5 | 4.9x#7 | 1.7x#8 | 10.4%#2 | 7.7%#6 | 6.6%#4 | 12.9%#3 | 17.4%#2 | — | — | — |
| AGL | $1.4B#5 | — | 3.0x#5 | 0.2x#3 | -2.1%#6 | -50.4%#8 | -7.8%#7 | -83.1%#8 | -117.6%#6 | — | — | — |
| VMD | $363M#7 | 26.5x#4 | 2.5x#4 | 1.3x#6 | 20.5%#1 | 35.1%#5 | 8.5%#3 | 10.7%#5 | 11.5%#3 | 6#2 | 47.7%#1 | — |
| PARK | $101M#8 | — | 3.4x#6 | — | — | — | — | 0.0%#6 | — | — | — | — |
| CCEL | $41M#9 | — | — | 1.3x#5 | -1.3%#5 | -704.2%#12 | 1.5%#5 | — | — | — | — | 7.9%#1 |
| MRAI | $25M#11 | — | — | 1.4x#7 | -35.8%#12 | 38.6%#4 | -74.9%#8 | — | — | — | — | — |
| MGRX | $5M#12 | — | 0.4x#3 | 11.3x#10 | -26.0%#11 | -137.1%#11 | -3954.3%#11 | -164.8%#9 | — | — | — | — |
| FMS | $6.3B#2 | — | — | — | — | — | — | — | — | — | — | — |
| MCTA | $471M#6 | — | 90.8x#10 | 97.9x#11 | -22.7%#10 | -101.9%#10 | -0.6%#6 | -0.4%#7 | 0.0%#5 | — | — | — |
| NIVF | $25140#13 | 0.0x#2 | 0.0x#2 | 0.0x#2 | -13.0%#8 | 1983.1%#1 | -226.9%#9 | 37.1%#1 | — | — | — | — |
| NIVFW | $1016#14 | 0.0x#1 | 0.0x#1 | 0.0x#1 | -13.0%#8 | 1983.1%#1 | -226.9%#9 | 37.1%#1 | — | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-11-02。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议